| Style | Citing Format |
|---|---|
| MLA | Asghari MH, Moloudizargari M, Abdollahi M. "Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics." Archives of Toxicology, vol. 92, no. 5, 2018, pp. 1907-1908. |
| APA | Asghari MH, Moloudizargari M, Abdollahi M (2018). Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics. Archives of Toxicology, 92(5), 1907-1908. |
| Chicago | Asghari MH, Moloudizargari M, Abdollahi M. "Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics." Archives of Toxicology 92, no. 5 (2018): 1907-1908. |
| Harvard | Asghari MH, Moloudizargari M, Abdollahi M (2018) 'Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics', Archives of Toxicology, 92(5), pp. 1907-1908. |
| Vancouver | Asghari MH, Moloudizargari M, Abdollahi M. Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics. Archives of Toxicology. 2018;92(5):1907-1908. |
| BibTex | @article{ author = {Asghari MH and Moloudizargari M and Abdollahi M}, title = {Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics}, journal = {Archives of Toxicology}, volume = {92}, number = {5}, pages = {1907-1908}, year = {2018} } |
| RIS | TY - JOUR AU - Asghari MH AU - Moloudizargari M AU - Abdollahi M TI - Reply to Zamani and Hassanian-Moghaddam, 2017: Being Specific and Targeting Disease-Causing Pathology Matter in Therapeutics JO - Archives of Toxicology VL - 92 IS - 5 SP - 1907 EP - 1908 PY - 2018 ER - |